PMVP
Pmv Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$66.66M
P/E Ratio
—
EPS
$-1.48
Beta
1.40
52W High
$1.88
52W Low
$0.81
50-Day MA
$1.30
200-Day MA
$1.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Pmv Pharmaceuticals Inc
PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-86.07M |
| Operating Margin | 0.00% |
| Return on Equity | -55.40% |
| Return on Assets | -35.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.96 |
| Price-to-Book | 0.68 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $53.33M |
| Float | $46.24M |
| % Insiders | 3.29% |
| % Institutions | 61.05% |
Analyst Ratings
Consensus ($7.75 target)
6
BuyData last updated: 4/9/2026